Adaptive Biotechnologies Corp 8-K

What Happened
Adaptive Biotechnologies Corporation (ADPT) filed a Form 8-K on January 12, 2026 announcing that it issued a press release with its financial results for the quarter and year ended December 31, 2025. The company also furnished an investor presentation that management intends to use in meetings with investors and analysts.

Key Details

• Filing date: January 12, 2026 (Form 8-K).
• Results covered: quarter and full year ended December 31, 2025 (press release attached as Exhibit 99.1).
• Investor materials: presentation dated January 12, 2026 furnished under Regulation FD and attached as Exhibit 99.2; company may update the presentation but disclaims any obligation to do so.
• Exhibits included: Exhibit 99.1 (press release), Exhibit 99.2 (investor presentation), and the Inline XBRL cover page (Exhibit 104).

Why It Matters
The 8-K signals that ADPT has publicly reported its latest quarterly and full-year financial results and provided investor-facing materials that may offer management’s context, metrics, and business updates. Retail investors should read the attached press release and investor presentation for the actual revenue, earnings, guidance (if any), and other operational details before making investment decisions.